Table 2.
Immune reaction to drugs
| Immunologic reactions | Pathogenesis | Need of sensitization | Dose dependence | Cross reactivity |
Allergic reactions
|
Drug modified peptide derived from intracellular haptenated protein | YES | NO | Based on affinity of immune receptors |
p-i reactions
|
Drug bind to the TCR or to HLA molecules outside of the antigen- binding groove through noncovalent interaction | NO | YES | Based on pharmacologic properties and type or HLA or TCR |
Reactions by altered repertoire model
|
Drugs bind within the antigen- binding groove of specific HLA molecules altering the repertoire of endogenous peptide ligands | NO | YES | Based on pharmacologic properties |
Pseudoallergic reactions
|
Reactions related to mast cell or eosinophil activation | NO | YES | Based on ligands on mast cells or eosinophils |